JPH02267112A - Organic complex clay mineral - Google Patents
Organic complex clay mineralInfo
- Publication number
- JPH02267112A JPH02267112A JP8737689A JP8737689A JPH02267112A JP H02267112 A JPH02267112 A JP H02267112A JP 8737689 A JP8737689 A JP 8737689A JP 8737689 A JP8737689 A JP 8737689A JP H02267112 A JPH02267112 A JP H02267112A
- Authority
- JP
- Japan
- Prior art keywords
- phospholipid
- clay minerals
- clay mineral
- powder
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002734 clay mineral Substances 0.000 title claims abstract description 44
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000001694 spray drying Methods 0.000 claims abstract description 14
- 239000002131 composite material Substances 0.000 claims description 22
- 239000002245 particle Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 abstract description 28
- 238000000034 method Methods 0.000 abstract description 13
- 239000003960 organic solvent Substances 0.000 abstract description 7
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 5
- 239000003974 emollient agent Substances 0.000 abstract description 4
- 239000010419 fine particle Substances 0.000 abstract description 3
- 102000002322 Egg Proteins Human genes 0.000 abstract description 2
- 108010000912 Egg Proteins Proteins 0.000 abstract description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 abstract description 2
- 235000013345 egg yolk Nutrition 0.000 abstract description 2
- 210000002969 egg yolk Anatomy 0.000 abstract description 2
- 238000004945 emulsification Methods 0.000 abstract description 2
- 229910052901 montmorillonite Inorganic materials 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 2
- 239000008158 vegetable oil Substances 0.000 abstract description 2
- 244000258044 Solanum gilo Species 0.000 abstract 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 10
- 239000000787 lecithin Substances 0.000 description 10
- 235000010445 lecithin Nutrition 0.000 description 10
- 229940067606 lecithin Drugs 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 229940094522 laponite Drugs 0.000 description 7
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- -1 sabonite Inorganic materials 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical class CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、リン脂質と、粘土鉱物と、水とからなる水性
ゲルを噴霧乾燥して得られる有機複合粘土鉱物に関する
。この方法により有機溶媒を用いることなく、簡便に球
状に近い形状の微粒子の有機複合粘土鉱物が得られ、こ
れらは使用感触を重視する化粧品などに有利に配合され
る。特に水性ゲル中のリン脂質の会合体の粒子径が1μ
m以下の場合、リン脂質を均一に含み、また、リン脂質
の安定性を著しく上昇させる効果に優れた有機変性粘土
鉱物が得られ好ましい。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to an organic composite clay mineral obtained by spray-drying an aqueous gel consisting of a phospholipid, a clay mineral, and water. By this method, organic composite clay minerals in the form of fine particles with a shape close to spherical can be easily obtained without using an organic solvent, and these can be advantageously incorporated into cosmetics and the like in which the feeling of use is important. In particular, the particle size of the phospholipid aggregate in the aqueous gel is 1 μm.
When it is less than m, it is preferable because an organically modified clay mineral containing phospholipids uniformly and having an excellent effect of significantly increasing the stability of phospholipids can be obtained.
[従来の技術]
リン脂質を含有した有機複合粘土鉱物は、化粧品などに
配合した場合、リン脂質により、しっとりした使用感触
と優れたエモリエント効果が発揮できる。これを製造す
るに際しては、−殻内なリン脂質は水に溶解しないこと
から、クロロホルムなどの有機溶媒に溶解し、そこに粘
土鉱物を分散させた後、有機溶媒を留去する方法が考え
られる。[Prior Art] When an organic composite clay mineral containing phospholipids is added to cosmetics, etc., the phospholipids can provide a moist feel and excellent emollient effect. When producing this, - Since the phospholipid in the shell is not soluble in water, a possible method is to dissolve it in an organic solvent such as chloroform, disperse clay minerals therein, and then distill off the organic solvent. .
しかしながらこの方法では有機溶媒の留去が面倒であり
、コストもかかり、かつ安全性の面からも問題があり、
大量製造するには非常に困難である。However, with this method, distilling off the organic solvent is troublesome, costly, and has safety issues.
It is extremely difficult to mass produce.
ざらにこのようにして得られた有機複合粘土鉱物は、最
初の粘土鉱物の形状や大きさを維持しており、化粧品な
どに配合した場合、ざらつき感があるなど必ずしも満足
のいく使用感触が得られにくいことが多い。The organic composite clay mineral obtained in this way maintains the shape and size of the original clay mineral, and when added to cosmetics etc., it does not necessarily give a satisfactory feel when used, such as a rough feeling. It is often difficult to
[発明が解決しようとする課題]
本発明者等は、こうした先行技術の欠点を改良すべく鋭
意研究を重ねた結果、リン脂質の会合体を含んだ粘土鉱
物の水性ゲルを噴霧乾燥することにより、上記欠点を解
消した優れた有機複合粉末が得られることを見出した。[Problems to be Solved by the Invention] As a result of extensive research to improve the shortcomings of the prior art, the present inventors have solved the problem by spray drying an aqueous clay mineral gel containing phospholipid aggregates. It has been discovered that an excellent organic composite powder can be obtained which eliminates the above-mentioned drawbacks.
すなわち、このような方法により有機溶媒を使用するこ
となく、簡便に大量に製造でき、また得られた有機複合
粘土鉱物はリン脂質を均一に含み、球状であることから
極めて滑かで、かつしっとりしたエモリエント効果を有
する粉末であることを見出して本発明を完成するに至っ
た。In other words, this method can be easily produced in large quantities without using organic solvents, and the resulting organic composite clay mineral contains phospholipids uniformly and is spherical, making it extremely smooth and moist. The present invention was completed based on the discovery that the powder has an emollient effect.
[課題を解決するための手段]
すなわち、本発明はリン脂質と、粘土鉱物と、水とから
なる水性ゲルを噴霧乾燥して得られる有機複合粘土鉱物
に関する。[Means for Solving the Problems] That is, the present invention relates to an organic composite clay mineral obtained by spray-drying an aqueous gel consisting of a phospholipid, a clay mineral, and water.
以下、本発明の構成について述べる。The configuration of the present invention will be described below.
本発明に用いる粘土鉱物はスメクタイト属に属する層状
ケイ酸塩鉱物であり、一般にはモンモリロナイト、バイ
デライト、ノントロナイト、サボナイト及び、ヘクトラ
イト等があり、これらは天然又は合成品のいずれであっ
てもよい。市販品では、クニピア、スメクトン(いずれ
もクニミネ工業)、ビーガム(バンダービルド社)、ラ
ポナイト(ラボルテ社)、フッ素四ケイ素雲母(トピー
工業)等が利用できる。本発明の実施にあたっては、こ
れらの粘土鉱物のうちから、一種または二種以上が任意
に選択される。The clay mineral used in the present invention is a layered silicate mineral belonging to the genus smectite, and generally includes montmorillonite, beidellite, nontronite, sabonite, and hectorite, and these minerals may be natural or synthetic. good. Commercially available products include Kunipia, Smectone (all manufactured by Kunimine Industries), Veegum (Vanderbild), Laponite (Laborte), and Fluorotetrasilicon Mica (Topy Industries). In carrying out the present invention, one or more types of clay minerals are arbitrarily selected from among these clay minerals.
本発明に用いるリン脂質は、卵黄もしくは植物油から抽
出され、場合によっては精製きれたリン脂質含有物、ま
たはその水素添加物、あるいは合成グリセロリン脂質エ
ステルおよびこれらの混合物を言うが、本発明において
は、好ましくはヨウ素価10以下になるまで水素添加し
たレシチンを用いるとレシチン自身が過酸化を受けに<
<、系に色調、匂の変化がなく安定性にも優れた系が得
られる。The phospholipid used in the present invention refers to a phospholipid-containing substance extracted from egg yolk or vegetable oil and purified in some cases, or a hydrogenated product thereof, or a synthetic glycerophospholipid ester and a mixture thereof. In the present invention, Preferably, if lecithin is hydrogenated to an iodine value of 10 or less, the lecithin itself will not be peroxidized.
A system with excellent stability without any change in color tone or odor can be obtained.
本発明の有機複合粘土鉱物は上記粘土鉱物に、リン脂質
を含有してなる粉末である。The organic composite clay mineral of the present invention is a powder containing the above clay mineral and phospholipid.
有機複合粘土鉱物全量中の粘土鉱物の含有量は25〜9
9.5重量%が好ましく、さらに好ましくは50〜90
.0重量%であり、有機複合粘土鉱物全量中の、リン脂
質の含有量は0.05〜75重量%が好ましく、さらに
好ましくはOII’ 1〜50重量%である。The content of clay minerals in the total amount of organic composite clay minerals is 25 to 9
9.5% by weight is preferred, more preferably 50-90%
.. 0% by weight, and the content of phospholipids in the total amount of organic composite clay mineral is preferably 0.05 to 75% by weight, more preferably 1 to 50% by weight OII'.
本発明の水性ゲルの製造方法としては、粘土鉱物の水分
散液と、リン脂質の水分散液とを混合する方法、あるい
は粘土鉱物と、リン脂質と、水とを直接混合する方法等
が挙げられる。この時リン脂質の会合体が小さげれば小
さいほど、最終的に得られる有機複合粉末中に均一に包
含され、またこの粉末の形状もきれいな球形となり易い
。そのような小ざなリン脂質会合体を得る方法としては
、以下の様な高圧乳化法を用いるのが好ましい。Examples of the method for producing the aqueous gel of the present invention include a method of mixing an aqueous dispersion of clay minerals and an aqueous dispersion of phospholipids, or a method of directly mixing clay minerals, phospholipids, and water. It will be done. At this time, the smaller the phospholipid aggregates are, the more uniformly they are included in the finally obtained organic composite powder, and the easier it is for this powder to have a neat spherical shape. As a method for obtaining such small phospholipid aggregates, it is preferable to use the following high-pressure emulsification method.
すなわち、リン脂質の水分散液、あるいは粘土鉱物とリ
ン脂質と水との混合物を、強力な剪断力で処理する方法
である。That is, this is a method in which an aqueous dispersion of phospholipids or a mixture of clay minerals, phospholipids, and water is treated with strong shearing force.
ここで、強力な剪断力処理とは、通常化粧品などの製造
に用いられるホモミキサーよりも強力なシェアーをかけ
られる乳化機、例えばマントンボウリン、フレンチプレ
ス、超音波乳化機などが挙げられる。この処理は系全量
を行なってもよいし、場合によっては一部を処理し、そ
の後に水あるいは多価アルコール等の他の配合物により
希釈してもよい。Here, the strong shearing force treatment includes emulsifiers that can apply a stronger shear than the homomixer normally used in the production of cosmetics, such as a Manton-Bourin, French press, and ultrasonic emulsifier. This treatment may be performed on the entire system, or in some cases, a portion may be treated and then diluted with water or other compounds such as polyhydric alcohols.
本発明において強力な剪断力処理を行なう前に、通常用
いられているホモミキサーなどにより予備分散を行なう
ことが望ましい。In the present invention, it is desirable to perform preliminary dispersion using a commonly used homomixer or the like before performing strong shearing force treatment.
すなわち、まずリン脂質を水性溶剤中に分子状に分散ま
たは溶解する。この時、加温処理やデイスパーまたはホ
モミキサーによる撹拌処理を行なってもよい。また、こ
の時場合によっては少量の水を加えてもよい。That is, first, phospholipids are dispersed or dissolved in molecular form in an aqueous solvent. At this time, heating treatment or stirring treatment using a disper or homomixer may be performed. Further, at this time, a small amount of water may be added depending on the case.
次に得られた水性溶剤相に水相を撹拌しつつ添加するこ
とにより予備分散液を得る。Next, a preliminary dispersion liquid is obtained by adding the aqueous phase to the obtained aqueous solvent phase while stirring.
ここでいう水性溶媒としては、例えば、エチレングリコ
ール、プロピレングリコニル、1.3−ブチレングリコ
ール、ジプロピレングリコール、グリセリン、ジグリセ
リン、トリグリセリン、テトラブレセリンなどのポリグ
リセリン、グルコース、マルトース、マルチトール、蔗
糖、フラクトース、キシリトール、イノシトール、ペン
タエリスリトール、ソルビトール、マルトトリオース、
V検分解糖、V検分解糖還元アルコールなどが挙げられ
る。Examples of the aqueous solvent here include polyglycerols such as ethylene glycol, propylene glyconyl, 1,3-butylene glycol, dipropylene glycol, glycerin, diglycerin, triglycerin, and tetrabrecerin, glucose, maltose, and maltitol. , sucrose, fructose, xylitol, inositol, pentaerythritol, sorbitol, maltotriose,
Examples include V-analyzable sugar and V-analyzable sugar reduced alcohol.
ここでいう水相としては、例えばビタミンB群、ビタミ
ンCおよびその誘導体、パントテン酸およびその誘導体
、ビオチン等のビタミン類、などの水溶性活性物質、グ
ルタミン酸ナトリウム、アルギニン、アスパラギン酸、
クエン酸、酒石酸、乳酸などの緩衝剤、EDTAなとの
キレート剤、2−ヒドロキシ−4−メトキシベンゾフェ
ノン−5−硫酸ナトリウムなどの紫外線吸収剤、各種色
素の一種又は二種以上の水溶液が挙げられる。The aqueous phase here includes, for example, water-soluble active substances such as B group vitamins, vitamin C and its derivatives, pantothenic acid and its derivatives, vitamins such as biotin, monosodium glutamate, arginine, aspartic acid,
Examples include buffering agents such as citric acid, tartaric acid, and lactic acid, chelating agents such as EDTA, ultraviolet absorbers such as sodium 2-hydroxy-4-methoxybenzophenone-5-sulfate, and aqueous solutions of one or more types of various dyes. .
これらの物質は噴霧乾燥後の有機複合粉末中に取り込ま
れる。These substances are incorporated into the organic composite powder after spray drying.
このように強力な剪断力処理で得られたリン脂質の会合
体の太きざは数μm以下にすることがてきる。リン脂質
を最終的に得られる有機複合粉末中に均一に包含するた
めに、あるいはきれいな球状にするためには、リン脂質
の会合体の粒径は1μm以下が好ましく、さらに好まし
くは0.3μm以下である。The width of the phospholipid aggregate obtained by such a strong shear treatment can be reduced to several micrometers or less. In order to uniformly include phospholipids in the finally obtained organic composite powder or to form a neat spherical shape, the particle size of the phospholipid aggregates is preferably 1 μm or less, more preferably 0.3 μm or less. It is.
ここでのリン脂質の会合体の粒径は、例えば動的光散乱
法(IIIAc ROYCO社製サブミクすン粒度分布
&lI定機−ナイコンプModel 270−など)で
測定できる。The particle size of the phospholipid aggregate can be measured, for example, by a dynamic light scattering method (IIIAc ROYCO submixed particle size distribution &lI machine - Nycomp Model 270, etc.).
また、噴霧乾燥するに際して、ゲル中の粘土鉱物の濃度
は10重量%以下が好ましく、それ以上の濃度ではゲル
粘度が高くなり過ぎて噴霧乾燥時の噴霧ノズルの液の送
りが難しく、またノズルの目詰り等が生じてしまう。と
くに好ましい濃度範囲は1〜10重量%である。In addition, when performing spray drying, the concentration of clay mineral in the gel is preferably 10% by weight or less; if the concentration is higher than that, the viscosity of the gel becomes too high, making it difficult to feed the liquid through the spray nozzle during spray drying. This may cause clogging, etc. A particularly preferred concentration range is 1 to 10% by weight.
ゲルの調製に際しては、粘土鉱物等が、十分に分散、膨
潤するように十分に撹拌することが好ましく、分散、膨
潤が不十分な場合は噴霧乾燥時にノズルの目詰りや、得
られた有機複合粘土鉱物が不揃いとなる場合があり好ま
しくない。When preparing a gel, it is preferable to sufficiently stir the clay minerals, etc. so that they are sufficiently dispersed and swollen. If the dispersion and swelling are insufficient, the nozzle may become clogged during spray drying, and the resulting organic composite may become clogged. Clay minerals may become irregular, which is not preferable.
噴霧乾燥は、ディスクタイプや加圧ノズル式、2流体ノ
ズル式などの一般的噴霧乾燥法か適用できる。For the spray drying, a general spray drying method such as a disk type, a pressure nozzle type, or a two-fluid nozzle type can be applied.
いずれの場合も噴霧時の入口空気温度はリン脂質や膨潤
性粘土鉱物が熱的に安定である温度域が好ましく、15
0〜300℃程度である。In either case, the inlet air temperature during spraying is preferably in a temperature range where phospholipids and swelling clay minerals are thermally stable;
The temperature is about 0 to 300°C.
また排気温度はノズルからの噴霧流量などによって規定
きれるが、大量100℃前後で良い。Further, the exhaust temperature can be determined by the flow rate of the spray from the nozzle, etc., but a temperature of about 100° C. is sufficient for a large amount.
こうして得られる粘土鉱物は、粘土鉱物の一次粒子が凝
集した構造を有する、球状の粉末であり、粒子径は2〜
20μmである。また粒子表面の形態はあらかじめ調製
したゲルの外観が透明であり粘度が高い(例えば、ラポ
ナイトの場合)程、均一でなめらかなものとなる。The clay mineral thus obtained is a spherical powder having a structure in which primary particles of clay mineral aggregate, and the particle size is 2 to 2.
It is 20 μm. Furthermore, the more transparent the appearance of the gel prepared in advance and the higher the viscosity (for example, in the case of laponite), the more uniform and smooth the particle surface morphology becomes.
[発明の効果]
本発明の方法により得られたリン脂質と粘土鉱物の有機
複合粘土鉱物は、製造においては、有機溶媒を使用しな
いことからコスト面、安全性の面から優れており、簡単
に大量製造でき、また得られた粉末は、リン脂質を均一
に含み、微粒子で球状となっている。このことからこの
粉末を化粧品などに配合すると、リン脂質によりエモリ
エント効果があるしっとりした感触と、球状の微粒子で
あることから滑かな使用感触を与えることができ、また
、リン脂質の安定性を著しく上昇させることができる。[Effects of the Invention] The organic composite clay mineral of phospholipid and clay mineral obtained by the method of the present invention is superior in terms of cost and safety because no organic solvent is used in its production. It can be produced in large quantities, and the resulting powder contains phospholipids uniformly and is finely spherical. Therefore, when this powder is blended into cosmetics, etc., the phospholipids give it a moist feel with an emollient effect, and the spherical fine particles give it a smooth feel, and it also significantly improves the stability of the phospholipids. can be raised.
[実施例]
次に本発明の一層の理解のために、実施例をあげて更に
詳細に説明する。本発明はこれによって限定されるもの
ではない。配合量は全て重量%とする。[Example] Next, in order to further understand the present invention, the present invention will be described in more detail by giving examples. The present invention is not limited thereby. All compounding amounts are in weight%.
実施例1
■水添大豆レシチン 2.0■メ
ヂルパラベン 0.1■イオン
交換水 残余(製造法)
Φ〜■を70℃加温後、ホモミキサーにより撹拌し、そ
の後マントンボウリンにより6000ps iで】0回
処理を行ない、リン脂質の会合体の粒径が0.1μm以
下の水性透明液を得た。Example 1 ■Hydrogenated soybean lecithin 2.0■Medylparaben 0.1■Ion-exchanged water Residue (manufacturing method) Φ~■ was heated to 70°C, stirred with a homomixer, and then stirred with a Manton-Bourin at 6000 psi]0 The treatment was carried out twice to obtain a transparent aqueous liquid in which the particle size of phospholipid aggregates was 0.1 μm or less.
このレシチン分散液500mσを水ILに加え、そこに
ラポナイトXLG 30gを撹拌しながら分散きぜ、ゲ
ルを調製する。このゲルをディスク式噴霧乾燥器により
、ディスク回転数20 、 OOOrpm %入口温度
180℃、排気温度110℃で噴霧乾燥したところ2〜
20μmの球状粉末が38g得られた。500 mσ of this lecithin dispersion was added to water IL, and 30 g of Laponite XLG was dispersed therein with stirring to prepare a gel. This gel was spray-dried using a disk-type spray dryer at a disc rotation speed of 20, an OOOrpm% inlet temperature of 180°C, and an exhaust temperature of 110°C.
38 g of spherical powder of 20 μm was obtained.
実施例2
実施例1で得られた球状の複合化粘土鉱物を配合したパ
ウダリーフアンプ−ジョンを製造した。Example 2 A powder leaf amplifier containing the spherical composite clay mineral obtained in Example 1 was manufactured.
■実施例1の複合粉末 8.1■タル
ク 29.0■マイカ
45.4■酸化鉄赤
1.0■酸化鉄黄
0.5■酸化鉄黒
0.5■酸化チタン
5.0■流動パラフイン
5.0■ラノリン
5.0[相]エチルパラベン
0.30香料
0.2(製法)
粉末をそれぞれヘンシェルミキサーに仕込み、均一撹拌
した後に残りの成分を添加し均一に混合した。混合物を
アトマイザ−で粉砕し、中皿に成型しパウダリーフアン
プ−ジョンを得た。■Composite powder of Example 1 8.1■Talc 29.0■Mica 45.4■Iron oxide red 1.0■Iron oxide yellow
0.5 ■ Iron oxide black
0.5 ■Titanium oxide
5.0■Liquid paraffin
5.0 ■ Lanolin
5.0 [Phase] Ethylparaben
0.30 fragrance
0.2 (Manufacturing method) Each powder was placed in a Henschel mixer and stirred uniformly, then the remaining ingredients were added and mixed uniformly. The mixture was pulverized with an atomizer and molded into a medium plate to obtain a powder leaf amplifier.
比較例1
実施例2で用いた複合粉末の代りにマイカを用いて同様
の方法でパウダリーフアンプ−ジョンを製造した。Comparative Example 1 A powder leaf amplifier was produced in the same manner as in Example 2, using mica instead of the composite powder.
比較例2
実施例2で用いた複合粉末の代りに、粉末部に水添大豆
レシチンを28 NラポナイトXLGを68 Nメチル
パラベンを0.1g配合し、同様の方法でパウダリーフ
アンデージ3ンを製造した。Comparative Example 2 Instead of the composite powder used in Example 2, 0.1 g of hydrogenated soybean lecithin, 28 N Laponite XLG, and 68 N methylparaben were mixed in the powder part, and Powder Leaf Andage 3 was produced in the same manner. .
実施例1と、比較例1.2、のパネル20名による使用
テスト結果を表1に示す。評価は官能により行ない、以
下の1〜505段階の評価を付して行った。Table 1 shows the usage test results of Example 1 and Comparative Examples 1.2 by 20 panelists. The evaluation was performed by sensory evaluation using the following 1-505 scale.
1・・・・・・悪い 2・・・・・・やや悪い 3・・・・・・普通 4・・・・・・やや良い 5・・・・・・良い 結果は平均値で次のように表した。1...Bad 2...Slightly bad 3・・・・・・Normal 4...somewhat good 5...Good The results were expressed as average values as follows.
0・・・・・・4.5〜5.0
0・・・・・・3.5〜4.4
△・・・・・・2.5〜3.4
×・・・・・・1.5〜2.4
表1:パウダリーファンデーションの品質特性表1の結
果から明らかなようにレシチンを複合化した球状粘土鉱
物を用いると、レシチンによりしっとりした感触が得ら
れ、また複合粉末が球状であることからなめらかな使用
性となり、更にはレシチン単独では臭い安定性が悪いが
、このように複合化により臭いも問題無いファンデーシ
ョンとなった。0...4.5-5.0 0...3.5-4.4 △...2.5-3.4 ×...1 .5~2.4 Table 1: Quality characteristics of powder foundation As is clear from the results in Table 1, when spherical clay minerals compounded with lecithin are used, lecithin provides a moist feel, and the composite powder has a spherical shape. Because of this, it is smooth to use, and lecithin alone has poor odor stability, but by combining lecithin in this way, the foundation has no odor problems.
実施例3
Φ水添大豆レシチン 2.50メ
チルパラベン 0.1■グリセ
リン 10.OOイオン交
換水 残余(製造法)
Φ〜■を70℃加温後、ホモミキサーにより撹拌しなが
ら■を除温した。その後超音波照射を行ない、リン脂質
の会合体の粒径が0.1μm以下の水性透明液を得た。Example 3 ΦHydrogenated soybean lecithin 2.50 Methylparaben 0.1■ Glycerin 10. OO ion-exchanged water residue (manufacturing method) After heating Φ to ■ to 70°C, the temperature of ■ was removed while stirring with a homomixer. Thereafter, ultrasonic irradiation was performed to obtain a transparent aqueous liquid in which the particle size of phospholipid aggregates was 0.1 μm or less.
次に水11にラポナイトXLG 30gを撹拌しながら
分散させる。得られたゲルに上記のようにして調製した
レシチン含有の水溶液を500m l加え、ざらに撹拌
する。その後実施例1と同様に噴霧乾燥し、2〜20μ
mの球状粉末が42g得られた。Next, 30 g of Laponite XLG is dispersed in water 11 with stirring. Add 500 ml of the lecithin-containing aqueous solution prepared as described above to the resulting gel and stir roughly. Thereafter, spray drying was carried out in the same manner as in Example 1, and 2 to 20μ
42 g of spherical powder of m was obtained.
この粉末を実施例2と同様にしてパウダリーファンデー
ションに配合したところ、使用性、臭い安定性ともに優
れたファンデーションが得られた。When this powder was blended into a powder foundation in the same manner as in Example 2, a foundation with excellent usability and odor stability was obtained.
実施例4
■水添卵黄レシチン 1.0■ラ
ポナイトXLG 3.0■イ
オン交換水 残余(製造法)
Φ〜■を70℃加温後、ホモミキサーにより撹拌し、そ
の後マントンボウリンにより6000ps iで10回
処理を行ない、リン脂質の会合体の粒径が0.1μm以
下の水性透明液を得た。Example 4 ■ Hydrogenated egg yolk lecithin 1.0 ■ Laponite XLG 3.0 ■ Ion-exchanged water Residue (manufacturing method) Φ ~ ■ was heated to 70°C, stirred with a homomixer, and then heated with a Manton-Bourin at 6000 psi for 10 The treatment was carried out twice to obtain a transparent aqueous liquid in which the particle size of phospholipid aggregates was 0.1 μm or less.
この液L Lを実施例1と同様に噴霧乾燥し、2〜20
μmの球状粉末が35g得られた。This liquid L L was spray-dried in the same manner as in Example 1, and
35 g of μm spherical powder was obtained.
(製造法)
■■を■に添加し、70℃に加温してホモミキサーによ
り充分に混合した。この混合液に70℃に加温した■を
撹拌しつつ除温し、その後にマントンボウリンにより6
000ps iで10回処理して微細なレシチンの分散
系を得た。(Manufacturing method) ■■ was added to ■, heated to 70°C, and thoroughly mixed using a homomixer. This mixture was heated to 70°C and cooled while stirring, and then heated to 60°C using a Manton Bowlin.
A fine lecithin dispersion was obtained by processing 10 times at 000 psi.
次に水11にラポナイトXLG 30gを撹拌しながら
分散きせる。得られたゲルに上記のようにして調製した
レシチン分散液を50m l加え、ざらに撹拌する。そ
の後実施例1と同様に噴霧乾燥し、2〜20μmの球状
粉末が35g得られた。Next, 30 g of Laponite XLG was dispersed in water 11 while stirring. Add 50 ml of the lecithin dispersion prepared as described above to the resulting gel and stir roughly. Thereafter, spray drying was performed in the same manner as in Example 1 to obtain 35 g of spherical powder with a diameter of 2 to 20 μm.
実施例5 ■水添大豆レシチン ■メチルパラベン ■グリセリン ■イオン交換水 2.0 0.1 10.0 残余 特許出願人 株式会社 資 生 堂Example 5 ■Hydrogenated soy lecithin ■Methylparaben ■Glycerin ■Ion exchange water 2.0 0.1 10.0 remainder Patent applicant: Shiseido Co., Ltd.
Claims (2)
を噴霧乾燥して得られる有機複合粘土鉱物。(1) Organic composite clay mineral obtained by spray drying an aqueous gel consisting of phospholipid, clay mineral, and water.
において、水性ゲル中のリン脂質の会合体の粒子径が1
μm以下である水性ゲルを噴霧乾燥して得られる有機複
合粘土鉱物。(2) In an aqueous gel consisting of phospholipids, clay minerals, and water, the particle size of the phospholipid aggregates in the aqueous gel is 1
An organic composite clay mineral obtained by spray-drying an aqueous gel having a particle size of less than μm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8737689A JPH02267112A (en) | 1989-04-06 | 1989-04-06 | Organic complex clay mineral |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8737689A JPH02267112A (en) | 1989-04-06 | 1989-04-06 | Organic complex clay mineral |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH02267112A true JPH02267112A (en) | 1990-10-31 |
Family
ID=13913179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8737689A Pending JPH02267112A (en) | 1989-04-06 | 1989-04-06 | Organic complex clay mineral |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH02267112A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012201550A (en) * | 2011-03-25 | 2012-10-22 | Kunimine Industries Co Ltd | Organification-treated clay dispersion, and method for producing the same |
-
1989
- 1989-04-06 JP JP8737689A patent/JPH02267112A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012201550A (en) * | 2011-03-25 | 2012-10-22 | Kunimine Industries Co Ltd | Organification-treated clay dispersion, and method for producing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4732759A (en) | Bath preparations and method for producing the same | |
| US4728510A (en) | Bath preparations and method for producing the same | |
| US6280746B1 (en) | Dry emollient compositions | |
| FR2642970A1 (en) | COSMETIC PRODUCT CONTAINING HYALURONIC AND ASCORBIC ACID DERIVATIVES | |
| JP3276937B2 (en) | Cosmetic and / or dermatological powder, method for producing the same and use thereof | |
| US20030180235A1 (en) | Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles | |
| JP2016008181A (en) | Kit for skin external preparation | |
| SK281587B6 (en) | COSMETIC PREPARATION WITH KAOLINE CONTENT | |
| US20040180069A1 (en) | Cosmetic powder on a silica base and method for preparation | |
| JP2002504425A (en) | Matrix for producing microparticles or nanoparticles, method for producing said particles and particles obtained | |
| EP0861296A1 (en) | Dye migration | |
| JPH0717371B2 (en) | Spherical organic composite clay mineral and its production method | |
| JP2015214515A (en) | Kit for skin external preparation | |
| JPH02267112A (en) | Organic complex clay mineral | |
| JP3542531B2 (en) | Cosmetic powder and its use for removing or cleansing makeup from skin and mucous membranes | |
| JPS6366111A (en) | Cosmetic blended with spherical organic complex clay mineral | |
| JPH02267114A (en) | Organic complex clay mineral and cosmetic blended with same mineral | |
| JP5112928B2 (en) | Hairdressing composition | |
| JPS60224609A (en) | Makeup cosmetic | |
| JP2003335618A (en) | Wet powdery cosmetic | |
| USRE38141E1 (en) | Dry emollient compositions | |
| AT385654B (en) | Process for the production of oil-containing preparations in granule form for oral administration | |
| JP6648230B2 (en) | Skin preparation kit | |
| JP2514372B2 (en) | Cosmetics | |
| JPS62205165A (en) | Powder having surface coated with organic compound, production thereof and cosmetic containing same |